{"id":2637,"date":"2025-09-09T08:39:16","date_gmt":"2025-09-09T12:39:16","guid":{"rendered":"https:\/\/medicamentquebec.ca\/?p=2637"},"modified":"2025-10-14T09:28:47","modified_gmt":"2025-10-14T13:28:47","slug":"quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec","status":"publish","type":"post","link":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/","title":{"rendered":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec"},"content":{"rendered":"<p><span data-contrast=\"none\">Dans le cadre de son programme <\/span><em>Innovations en technologies vaccinales<\/em><span data-contrast=\"none\">, M\u00e9dicament Qu\u00e9bec investit 7,5\u202fmillions de dollars afin de soutenir six activit\u00e9s novatrices qui renforceront les capacit\u00e9s du Qu\u00e9bec en mati\u00e8re de recherche et de d\u00e9veloppement de vaccins. <\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Ces initiatives structurantes, soutenues par le gouvernement du Qu\u00e9bec et men\u00e9es en collaboration entre chercheurs universitaires et partenaires de l\u2019industrie, visent \u00e0 b\u00e2tir des plateformes, des outils et des pratiques durables qui auront des retomb\u00e9es concr\u00e8tes pour la soci\u00e9t\u00e9 qu\u00e9b\u00e9coise. En favorisant un arrimage solide entre la recherche acad\u00e9mique et les besoins r\u00e9els de l\u2019\u00e9cosyst\u00e8me, ces projets contribueront \u00e0 acc\u00e9l\u00e9rer l\u2019innovation et \u00e0 stimuler le d\u00e9veloppement de nouveaux vaccins.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><strong>Les activit\u00e9s financ\u00e9es sont:\u00a0<\/strong><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\">Pr Denis Leclerc, Universit\u00e9 Laval et\u00a0 Centre de recherche du CHU de Qu\u00e9bec : VaxSynergy \u2014 Affranchir l\u2019innovation dans le d\u00e9veloppement de vaccins gr\u00e2ce \u00e0 un \u00e9cosyst\u00e8me collaboratif<\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\">Pre Maryam Tabrizian,\u00a0 Universit\u00e9 McGill : Mise en place d\u2019une plateforme pour innover dans des vaccins th\u00e9rapeutiques \u00e0 base de nanoparticules immunomodulatrices d\u00e9riv\u00e9es de lipides bact\u00e9riens contre le cancer<\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Pr Gregory De\u00a0Crescenzo, Polytechnique Montr\u00e9al : D\u00e9veloppement d\u2019une nouvelle plateforme CHO pour la fabrication de vaccins influenza intranasaux<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559737&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240,&quot;335559740&quot;:279}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Pr\u00a0J\u00e9r\u00f4me Estaquier, Universit\u00e9 Laval : Outils et services pr\u00e9cliniques pour d\u00e9chiffrer les r\u00e9pertoires de cellules B et T induits par la r\u00e9ponse immunitaire chez les primates non humains (PNH)<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559737&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240,&quot;335559740&quot;:279}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Pr\u00a0Bruno Gaillet, Universit\u00e9 Laval : Plateforme de nanoparticules lipidiques avec syst\u00e8me de fuite des endosomes actifs pour vaccins \u00e0 ARN <\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559737&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240,&quot;335559740&quot;:279}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"auto\">Pr\u00a0Ciriaco Piccirillo, Institut de recherche du Centre universitaire de sant\u00e9 McGill (IR-CUSM) : Cr\u00e9ation d\u2019un r\u00e9seau qu\u00e9b\u00e9cois d\u2019immunologie humaine pour soutenir l\u2019\u00e9cosyst\u00e8me provincial des vaccins<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559737&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240,&quot;335559740&quot;:279}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i>Voici les descriptions plus d\u00e9taill\u00e9es des activit\u00e9s de recherche financ\u00e9es:<\/i><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2832 alignleft\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Denis-Leclerc.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><strong><br \/>\nPr Denis Leclerc, professeur titulaire, d\u00e9partement de microbiologie-infectiologie et d\u2019immunologie, Universit\u00e9 Laval et Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval<\/strong><br \/>\n<strong>VaxSynergy \u2014 Affranchir l\u2019innovation dans le d\u00e9veloppement de vaccins gr\u00e2ce \u00e0 un \u00e9cosyst\u00e8me collaboratif &#8211; Financement de 1,5\u00a0M$<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Malgr\u00e9 les progr\u00e8s r\u00e9cents en recherche et d\u00e9veloppement vaccinal, r\u00e9v\u00e9l\u00e9s notamment pendant la pand\u00e9mie, un besoin demeure pressant\u00a0: celui d\u2019une plateforme int\u00e9gr\u00e9e pour accompagner efficacement les chercheurs et les petites et moyennes entreprises dans la conception et la mise au point de vaccins sous-unitaires et d\u2019adjuvants novateurs, du laboratoire jusqu\u2019aux applications cliniques.<\/p>\n<p>L\u2019activit\u00e9 VaxSynergy r\u00e9pond \u00e0 ce besoin en mettant en place une plateforme d\u2019ing\u00e9nierie et de biofabrication de nouvelle g\u00e9n\u00e9ration, qui regroupera des expertises compl\u00e9mentaires pour former un \u00e9cosyst\u00e8me collaboratif unique au Qu\u00e9bec. Cette plateforme int\u00e9gr\u00e9e permettra de rationaliser les processus de d\u00e9couverte, de r\u00e9duire les d\u00e9lais de d\u00e9veloppement et d\u2019acc\u00e9l\u00e9rer le passage des concepts scientifiques \u00e0 la preuve de concept clinique.<\/p>\n<p>VaxSynergy se distingue notamment par son portefeuille d\u2019adjuvants novateurs et par l\u2019int\u00e9gration d\u2019une prot\u00e9ine essentielle pour les vaccins conjugu\u00e9s. En combinant ces \u00e9l\u00e9ments avec des m\u00e9thodes de production \u00e9volutives et des approches bas\u00e9es sur l\u2019intelligence artificielle, la plateforme vise \u00e0 am\u00e9liorer l\u2019efficacit\u00e9, la stabilit\u00e9 et la rapidit\u00e9 de d\u00e9veloppement de nouveaux vaccins.<\/p>\n<p>Les retomb\u00e9es attendues sont multiples\u00a0:<\/p>\n<ul>\n<li>Fournir aux chercheurs et aux PME un acc\u00e8s \u00e0 des outils et services int\u00e9gr\u00e9s pour concevoir et tester leurs vaccins\u2009;<\/li>\n<li>Optimiser le couplage antig\u00e8nes\u2013adjuvants et explorer des modes d\u2019administration alternatifs comme la n\u00e9bulisation\u2009;<\/li>\n<li>G\u00e9n\u00e9rer une documentation conforme aux normes r\u00e9glementaires afin de faciliter le passage vers la clinique.<\/li>\n<\/ul>\n<p>Cette activit\u00e9 f\u00e9d\u00e8re une vaste \u00e9quipe multidisciplinaire\u00a0:<\/p>\n<p><strong>Chercheurs acad\u00e9miques\u00a0:<\/strong><\/p>\n<ul>\n<li>Denis Leclerc \u2013 Universit\u00e9 Laval \/ CHU de Qu\u00e9bec<\/li>\n<li>Steve Bourgault \u2013 UQAM<\/li>\n<li>Laurent Cappadocia \u2013 UQAM<\/li>\n<li>Jean-Fran\u00e7ois Lemay \u2013 CNETE<\/li>\n<li>Philippe Tessier \u2013 Universit\u00e9 Laval<\/li>\n<\/ul>\n<p><strong>Partenaires industriels et strat\u00e9giques\u00a0:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/glycovax.com\/\">Glycovax Pharma Inc.<\/a> \u2013 plateforme d\u2019immunoconjugu\u00e9s et adjuvants SLA<\/li>\n<li>Fondation Courtois<\/li>\n<li><a href=\"https:\/\/fondationduchudequebec.org\/\">Fondation du CHU de Qu\u00e9bec<\/a><\/li>\n<li><a href=\"https:\/\/proteo.ca\/\">Regroupement strat\u00e9gique PROTEO<\/a><\/li>\n<\/ul>\n<p>En fournissant aux chercheurs qu\u00e9b\u00e9cois une infrastructure int\u00e9gr\u00e9e et collaborative, VaxSynergy permettra de propulser l\u2019innovation vaccinale, de r\u00e9duire la d\u00e9pendance \u00e0 des technologies \u00e9trang\u00e8res et de renforcer la capacit\u00e9 du Qu\u00e9bec \u00e0 r\u00e9pondre rapidement aux besoins de sant\u00e9 publique.<\/p>\n<p>Cette activit\u00e9 b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 1,5 M$. \u00c0 cette contribution s\u2019ajoutent 0,8 M$ provenant de partenaires industriels, pour un investissement total de 2,3 M$.<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2834 alignright\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Maryam-Tabrizian.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><strong>Pre Maryam Tabrizian, professeure titulaire, d\u00e9partement de g\u00e9nie biom\u00e9dical, Universit\u00e9 McGill<\/strong><br \/>\n<strong>Activit\u00e9\u00a0: Mise en place d\u2019une plateforme pour innover dans des vaccins th\u00e9rapeutiques \u00e0 base de nanoparticules immunomodulatrices d\u00e9riv\u00e9es de lipides bact\u00e9riens contre le cancer<\/strong><br \/>\n<strong>\u2013 Financement de 0,8\u00a0M$<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Le cancer m\u00e9tastatique, responsable de pr\u00e8s de 90\u00a0% des d\u00e9c\u00e8s li\u00e9s au cancer dans le monde<\/strong>, demeure un d\u00e9fi m\u00e9dical majeur. Sa complexit\u00e9 tient \u00e0 l\u2019h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 g\u00e9n\u00e9tique des tumeurs, \u00e0 la capacit\u00e9 des cellules canc\u00e9reuses d\u2019\u00e9chapper au syst\u00e8me immunitaire et \u00e0 leur grande adaptabilit\u00e9. Les traitements conventionnels, comme la chirurgie, la radioth\u00e9rapie ou la chimioth\u00e9rapie, offrent peu de solutions contre les m\u00e9canismes de la m\u00e9tastase, ce qui m\u00e8ne souvent \u00e0 des r\u00e9cidives et \u00e0 un mauvais pronostic.<\/p>\n<p>Face \u00e0 ces limites, <strong>les vaccins th\u00e9rapeutiques apparaissent comme une approche prometteuse<\/strong> en mobilisant le syst\u00e8me immunitaire pour cibler directement les cellules canc\u00e9reuses. Toutefois, plusieurs obstacles persistent, notamment l\u2019identification d\u2019antig\u00e8nes tumoraux pertinents et la mise au point de syst\u00e8mes d\u2019administration efficaces.<\/p>\n<p>L\u2019activit\u00e9 de la Pre Tabrizian vise \u00e0 d\u00e9velopper une p<strong>lateforme innovante exploitant des nanoparticules lipidiques hybrides (hLNPs) d\u00e9riv\u00e9es de bact\u00e9ries<\/strong> pour concevoir de nouveaux vaccins \u00e0 base d\u2019ARN contre le cancer. Ces hLNPs combinent des lipides d\u2019origine bact\u00e9rienne \u00e0 des lipides synth\u00e9tiques, offrant une meilleure biocompatibilit\u00e9, stabilit\u00e9 et efficacit\u00e9 de livraison de l\u2019ARN que les nanoparticules classiques. Elles peuvent aussi \u00eatre produites \u00e0 grande \u00e9chelle gr\u00e2ce \u00e0 des bact\u00e9ries g\u00e9n\u00e9tiquement modifi\u00e9es, r\u00e9duisant ainsi les co\u00fbts de fabrication et rendant possible le criblage \u00e0 haut d\u00e9bit.<\/p>\n<p>Pour y parvenir, l\u2019activit\u00e9 int\u00e9grera de multiples plateformes pour le design, la caract\u00e9risation, l\u2019\u00e9valuation et la validation des hLNPs, comprenant\u00a0:<\/p>\n<ul>\n<li>Outils de conception assist\u00e9e par intelligence artificielle et apprentissage automatique pour optimiser les formulations, identifier des tendances dans les donn\u00e9es, r\u00e9duire les processus d\u2019essais-erreurs et pr\u00e9dire les performances des hLNPs.<\/li>\n<li>Analyses in <em>vitro, in vivo<\/em> et sur organes-sur-puce pour valider la stabilit\u00e9, l\u2019efficacit\u00e9 et l\u2019activation du syst\u00e8me immunitaire.<\/li>\n<li>Criblage \u00e0 haut d\u00e9bit afin d\u2019acc\u00e9l\u00e9rer l\u2019identification des formulations les plus prometteuses.<\/li>\n<li>Outils bioinformatiques coupl\u00e9s \u00e0 l\u2019apprentissage automatique pour affiner la s\u00e9lection des candidats.<\/li>\n<\/ul>\n<p>Cette approche multiplateforme int\u00e9gr\u00e9e permettra d\u2019identifier rapidement les vaccins \u00e0 base d\u2019ARN les plus prometteurs et de faciliter leur passage vers les essais cliniques.<\/p>\n<p>Ce projet rassemble une vaste \u00e9quipe multidisciplinaire\u00a0:<\/p>\n<p><strong>Chercheurs acad\u00e9miques\u00a0:<\/strong><\/p>\n<ul>\n<li>Maryam Tabrizian \u2013 Professeure titulaire, G\u00e9nie biom\u00e9dical, Universit\u00e9 McGill<\/li>\n<li>Julia Valdemarin Burnier \u2013 Professeure adjointe, Universit\u00e9 McGill,<\/li>\n<li>Guojun Chen \u2013 Professeur adjoint, G\u00e9nie biom\u00e9dical, Universit\u00e9 McGill<\/li>\n<li>Thomas Duchaine \u2013 Professeur titulaire, Biochimie, Institut du cancerGoodman, Universit\u00e9 McGill et directeur scientifique plateforme th\u00e9rapeutique \u00e0 ARNm<\/li>\n<li>Paul Fran\u00e7ois \u2013 Professeur titulaire, Biochimie et m\u00e9decine mol\u00e9culaire, Universit\u00e9 de Montr\u00e9al IVADO &amp; Mila<\/li>\n<li>Marc Lavertu \u2013 Professeur agr\u00e9g\u00e9, G\u00e9nie chimique, Polytechnique Montr\u00e9al<\/li>\n<li>Sara Mahshid \u2013 Professeure adjointe, G\u00e9nie biom\u00e9dical, Universit\u00e9 McGill<\/li>\n<li>Ian Watson \u2013 Professeur agr\u00e9g\u00e9, Biochimie Universit\u00e9 McGill<\/li>\n<\/ul>\n<p><strong>Partenaires industriels\u00a0:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.nanofacile.bio\/fr\">Nanofacile<\/a>, entreprise sp\u00e9cialis\u00e9e en nanofabrication et en d\u00e9veloppement de mat\u00e9riaux innovants<\/li>\n<li><a href=\"https:\/\/www.rnatechnologies.com\/\">RNA Technologies &amp; Therapeutics<\/a> (RNA T&amp;T), soci\u00e9t\u00e9 experte en conception et optimisation de technologies \u00e0 base d\u2019ARN<\/li>\n<li><a href=\"https:\/\/beetabiomed.com\/\">Beeta Biomed<\/a>, entreprise ax\u00e9e sur la mise au point de solutions biotechnologiques appliqu\u00e9es \u00e0 la sant\u00e9<\/li>\n<\/ul>\n<p>En combinant des approches de pointe en bioing\u00e9nierie, en intelligence artificielle et en immunologie, cette activit\u00e9 a le potentiel de transformer la recherche et le d\u00e9veloppement de vaccins th\u00e9rapeutiques contre le cancer et de positionner le Qu\u00e9bec parmi les leaders mondiaux de ce domaine \u00e9mergent.<\/p>\n<p>Cette activit\u00e9 b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 0,8\u00a0M$. \u00c0 cette contribution s\u2019ajoutent 0,4\u00a0M$ provenant de partenaires industriels, pour un investissement total de 1,1\u00a0M$.<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2638 size-medium alignleft\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Gregory-De-Crescenzo.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<h4><strong><span class=\"TextRun SCXW134582161 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW134582161 BCX0\">P<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">r<\/span> <span class=\"NormalTextRun SCXW134582161 BCX0\">Gregory De<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">\u202f<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW134582161 BCX0\">Crescenzo<\/span> <span class=\"NormalTextRun SCXW134582161 BCX0\">\u2013 <\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">D\u00e9partement de <\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">g\u00e9nie chimique<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">, <\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">Polytechnique Montr\u00e9al<\/span> <\/span><span class=\"LineBreakBlob BlobObject DragDrop SCXW134582161 BCX0\"><span class=\"SCXW134582161 BCX0\">\u00a0<\/span><br class=\"SCXW134582161 BCX0\" \/><\/span><span class=\"TextRun SCXW134582161 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW134582161 BCX0\">D\u00e9veloppement d\u2019une nouvelle plateforme CHO pour la fabrication de vaccins influenza intranasaux<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\"> &#8211; <\/span><\/span><span class=\"TextRun SCXW134582161 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW134582161 BCX0\">Financement de 1,43<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">\u202f<\/span><span class=\"NormalTextRun SCXW134582161 BCX0\">M$<\/span><\/span><span class=\"EOP SCXW134582161 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/strong><\/h4>\n<p><span data-contrast=\"none\">La <strong>grippe repr\u00e9sente un fardeau persistant<\/strong> pour le syst\u00e8me de sant\u00e9 publique du Qu\u00e9bec. Les vaccins contre la grippe saisonni\u00e8re requi\u00e8rent des rappels r\u00e9currents et co\u00fbteux, demandant une production \u00e9lev\u00e9e de vaccins ainsi qu\u2019une cha\u00eene d\u2019approvisionnement \u00e9labor\u00e9e.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Les techniques actuelles de production vaccinale pr\u00e9sentent des limites notables qui laissent place \u00e0 des am\u00e9liorations afin de mieux r\u00e9pondre aux besoins de sant\u00e9 publique. Par exemple, la grippe aviaire\u202fH5N1, qui devient une nouvelle menace de pand\u00e9mie, pourrait mettre la capacit\u00e9 de fabrication de vaccins standards \u00e0 base d\u2019\u0153ufs sous forte pression, tandis qu\u2019un vaccin ARNm reste encore risqu\u00e9, sous-optimal et tr\u00e8s co\u00fbteux avec sa cha\u00eene de froid obligatoire. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Cette activit\u00e9 de recherche vise \u00e0 d\u00e9velopper une <\/span><strong>plateforme de production de vaccins en bior\u00e9acteur<\/strong><span data-contrast=\"none\">\u00a0qui exploitera <\/span><strong>des pools stables de cellules CHO<\/strong><span data-contrast=\"none\"> au lieu de lign\u00e9es cellulaires stables, avec comme avantage notable de r\u00e9duire consid\u00e9rablement le temps de production des lots destin\u00e9s aux essais pr\u00e9cliniques in vivo et ayant le potentiel de contourner toute pand\u00e9mie \u00e9ventuelle d\u2019H5N1. De plus, des <\/span><strong>formulations intranasales lyophilis\u00e9es<\/strong><span data-contrast=\"none\"> seront d\u00e9velopp\u00e9es afin d\u2019\u00e9liminer la n\u00e9cessit\u00e9 d\u2019une cha\u00eene de froid tout en offrant aux patients un mode d\u2019administration mieux accept\u00e9.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Ce portefeuille de plateformes technologiques sera directement transf\u00e9rable \u00e0 l\u2019industrie et permettra la production rentable de vaccins antigrippaux \u00e0 base d\u2019antig\u00e8nes en bior\u00e9acteur.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Cette activit\u00e9 de recherche est soutenue par une \u00e9quipe multidisciplinaire incluant:\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"none\">Des professeurs de <\/span><strong><a href=\"https:\/\/www.polymtl.ca\/\">Polytechnique Montr\u00e9al<\/a><\/strong><span data-contrast=\"none\"> (Prs De Crescenzo, Henry, Guo) ;<\/span><\/li>\n<li><span data-contrast=\"none\">Des chercheurs <\/span>du <strong><a href=\"https:\/\/nrc.canada.ca\/fr\">Conseil national de recherches du Canada<\/a><\/strong><span data-contrast=\"none\"> (Prs Durocher, El\u202fBakkouri, Tran) ;<\/span><\/li>\n<li><span data-contrast=\"none\">Le partenaire industriel <\/span><strong><a href=\"https:\/\/www.biodextris.com\/fr\">Biodextris<\/a><\/strong> <span data-contrast=\"none\">impliqu\u00e9 dans la production de vaccins et de produits th\u00e9rapeutiques ;<\/span><\/li>\n<li>Le partenaire industriel <strong><a href=\"https:\/\/www.inspirevax.com\/\">Inspirevax<\/a><\/strong><span data-contrast=\"none\"><span data-contrast=\"none\">\u00a0qui se concentre sur la production d\u2019adjuvants pour r\u00e9pondre aux d\u00e9fis li\u00e9s \u00e0 l\u2019administration intranasale.<\/span><\/span><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">Ce projet b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 1,4 M$. \u00c0 cette contribution s\u2019ajoutent 0,7 M$ provenant de partenaires industriels, pour un investissement total de 2,1 M$.\u00a0<\/span><\/span><\/p>\n<hr \/>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2644 alignright\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Jerome-Estaquier.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<h4><\/h4>\n<p>&nbsp;<\/p>\n<h4 style=\"text-align: right;\"><strong><span class=\"TextRun SCXW205123397 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW205123397 BCX0\" data-ccp-charstyle=\"Titre 3 Car\">P<\/span><span class=\"NormalTextRun SCXW205123397 BCX0\" data-ccp-charstyle=\"Titre 3 Car\">r J\u00e9r\u00f4me <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW205123397 BCX0\" data-ccp-charstyle=\"Titre 3 Car\">Estaquier<\/span><span class=\"NormalTextRun SCXW205123397 BCX0\" data-ccp-charstyle=\"Titre 3 Car\"> \u2013 <span class=\"TextRun SCXW38020720 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW38020720 BCX0\">D<\/span><\/span><span class=\"TextRun SCXW38020720 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW38020720 BCX0\">\u00e9partement<\/span><span class=\"NormalTextRun SCXW38020720 BCX0\"> de microbiologie-infectiologie et d&#8217;immunologie<\/span><\/span>, Universit\u00e9 Laval<\/span><\/span><span class=\"LineBreakBlob BlobObject DragDrop SCXW205123397 BCX0\"><span class=\"SCXW205123397 BCX0\">\u00a0<\/span><br class=\"SCXW205123397 BCX0\" \/><\/span><span class=\"TextRun SCXW205123397 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW205123397 BCX0\">Outils et services pr\u00e9cliniques pour d\u00e9chiffrer les r\u00e9pertoires de cellules B et T induits par la r\u00e9ponse immunitaire chez les primates non humains (PNH)<\/span><span class=\"NormalTextRun SCXW205123397 BCX0\"> &#8211; <\/span><\/span><span class=\"TextRun SCXW205123397 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW205123397 BCX0\">Financement de 0,94<\/span><span class=\"NormalTextRun SCXW205123397 BCX0\">\u202f<\/span><span class=\"NormalTextRun SCXW205123397 BCX0\">M$<\/span><\/span><\/strong><\/h4>\n<p><span data-contrast=\"none\">Gr\u00e2ce \u00e0 leur forte ressemblance avec l\u2019humain, les primates non humains (PNH) sont essentiels pour <strong>mieux comprendre les maladies infectieuses et pour d\u00e9velopper et tester de nouveaux vaccins et traitements<\/strong>. Les interactions entre les cellules T et B au sein des organes lympho\u00efdes sont essentielles pour g\u00e9n\u00e9rer des cellules m\u00e9moires \u00e0 longue dur\u00e9e de vie et pour produire des anticorps capables de contr\u00f4ler les infections microbiennes. Mieux comprendre ces interactions est essentiel pour appr\u00e9hender la dynamique de ces cellules qui constituent notre principale d\u00e9fense vis-\u00e0-vis des agents infectieux.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">L\u2019\u00e9quipe de Pr Estaquier d\u00e9veloppera un <\/span><strong>outil permettant de caract\u00e9riser ces populations lymphocytaires \u00e0 l\u2019\u00e9chelle de la cellule<\/strong><span data-contrast=\"none\"> pour d\u00e9crypter et <\/span><strong>surveiller les r\u00e9ponses immunes T et B<\/strong><span data-contrast=\"none\"> chez les PNHs \u00e0 l\u2019aide d\u2019approches d\u2019analyse des g\u00e8nes sur cellule unique.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Une \u00e9quipe multidisciplinaire sera impliqu\u00e9e dans cette activit\u00e9 recherche et incluera:\u00a0<\/span><\/p>\n<ul>\n<li>Un sp\u00e9cialiste du s\u00e9quen\u00e7age \u00e0 haut d\u00e9bit et de l\u2019intelligence artificielle ;<\/li>\n<li><span data-contrast=\"none\">Un sp\u00e9cialiste de l\u2019immunologie des maladies infectieuses ;<\/span><\/li>\n<li><span data-contrast=\"none\">La <\/span><strong><a href=\"https:\/\/www.bd.com\/fr-ca\/about-bd\/our-company\">soci\u00e9t\u00e9 BD<\/a><\/strong><span data-contrast=\"none\">\u00a0qui soutient des recherches en maladies infectieuses \u00e0 travers diff\u00e9rents \u00e9quipements acquis pr\u00e9c\u00e9demment dans le d\u00e9veloppement de programmes sur les vaccins.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">Ce nouvel outil s\u2019int\u00e8grera au d\u00e9veloppement d\u2019une nouvelle infrastructure nationale financ\u00e9e par le <\/span><strong><a href=\"https:\/\/sshrc-crsh.canada.ca\/funding-financement\/cbrf-frbc\/index-fra.aspx\">Fond de Recherche Biom\u00e9dicale du Canada et le Fond pour l\u2019Infrastructure de Recherche en Sciences Biologiques<\/a><\/strong><span data-contrast=\"none\"><strong> (CBRF-BRIF)<\/strong>.<\/span> <span data-contrast=\"none\">En s\u2019appuyant sur une structure de d\u00e9veloppement de vaccins et d\u2019approches th\u00e9rapeutiques innovantes, cette nouvelle trousse apportera un soutien d\u00e9terminant \u00e0 l\u2019\u00e9cosyst\u00e8me industriel national et renforcera l\u2019offre de services disponible.<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">Ce projet b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 0,9 M$. \u00c0 cette contribution s\u2019ajoutent 0,4 M$ provenant de partenaires industriels, pour un investissement total de 1,1 M$. <\/span><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><span class=\"TextRun SCXW131823331 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW131823331 BCX0\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2640 alignleft\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Bruno-Gaillet.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><\/span><\/p>\n<h4><\/h4>\n<h4><strong><span class=\"TextRun SCXW131823331 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW131823331 BCX0\">P<\/span><\/span><span class=\"TextRun SCXW131823331 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW131823331 BCX0\">r Bruno Gaillet <\/span><span class=\"NormalTextRun SCXW131823331 BCX0\">\u2013 D\u00e9partement de g\u00e9nie chimique, Universit\u00e9 Laval<\/span><\/span> <span class=\"LineBreakBlob BlobObject DragDrop SCXW131823331 BCX0\"><span class=\"SCXW131823331 BCX0\">\u00a0<\/span><br class=\"SCXW131823331 BCX0\" \/><\/span><span class=\"TextRun SCXW131823331 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW131823331 BCX0\">Plateforme de nanoparticules lipidiques avec syst\u00e8me de fuite des endosomes actifs pour vaccins \u00e0 ARN <\/span><span class=\"NormalTextRun SCXW131823331 BCX0\">&#8211; <\/span><\/span><span class=\"TextRun SCXW131823331 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW131823331 BCX0\">Financement de 1,5<\/span><span class=\"NormalTextRun SCXW131823331 BCX0\">\u202f<\/span><span class=\"NormalTextRun SCXW131823331 BCX0\">M$<\/span><\/span><span class=\"EOP SCXW131823331 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/strong><\/h4>\n<p><span data-contrast=\"none\"><strong>Les nanoparticules lipidiques (LNP)<\/strong> ont jou\u00e9 un r\u00f4le crucial dans la mise au point rapide des<strong> vaccins \u00e0 ARNm<\/strong> contre la COVID-19, en prot\u00e9geant et en transportant l\u2019ARN messager jusqu\u2019aux cellules. Cependant, une grande partie de cet ARNm reste bloqu\u00e9e dans la cellule sans pouvoir produire l\u2019effet d\u00e9sir\u00e9\u202f: seule une petite fraction r\u00e9ussit \u00e0 atteindre sa cible. Am\u00e9liorer ce processus est essentiel pour rendre les vaccins plus efficaces, r\u00e9duire les doses n\u00e9cessaires et limiter les effets secondaires.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Afin d\u2019am\u00e9liorer l\u2019internalisation des ARNm, l\u2019\u00e9quipe du Pr Gaillet d\u00e9veloppera un syst\u00e8me de fuite des endosomes aux LNP afin de produire une <\/span><strong>plateforme r\u00e9volutionnaire capable d\u2019augmenter drastiquement le pourcentage d\u2019ARNm livr\u00e9<\/strong><span data-contrast=\"none\"> dans le cytoplasme des cellules.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">Plusieurs partenaires seront impliqu\u00e9s dans le projet: <\/span><\/p>\n<ul>\n<li><span data-contrast=\"none\">Des chercheurs de <\/span>l\u2019<strong><a href=\"https:\/\/www.ulaval.ca\/\">Universit\u00e9 Laval<\/a><\/strong><b><span data-contrast=\"none\"> ;<\/span><\/b><\/li>\n<li><span data-contrast=\"none\">Le partenaire industriel <\/span><strong><a href=\"https:\/\/www.feldan.com\/fr\/\">Feldan Th\u00e9rapeutiques <\/a><\/strong>qui <span data-contrast=\"none\">prendra en charge le d\u00e9veloppement de la plateforme et qui sera activement impliqu\u00e9 dans la lev\u00e9e des fonds n\u00e9cessaires pour son d\u00e9ploiement, ce qui aura un effet multiplicateur pour le financement de nouvelles technologies vaccinales au Qu\u00e9bec ;<\/span><\/li>\n<li><span data-contrast=\"none\">Le Centre Coll\u00e9gial de Transfert Technologique, <\/span><a href=\"https:\/\/www.transbio.tech\/\"><strong>TransBIOTech<\/strong><\/a><b><span data-contrast=\"none\">,<\/span><\/b><span data-contrast=\"none\"> \u00e9valuera la technologie dans le mod\u00e8le animal appropri\u00e9.<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">En plus de d\u00e9velopper une plateforme am\u00e9liorant l\u2019efficacit\u00e9 des vaccins ARNm, cette activit\u00e9 favorisera la <strong>cr\u00e9ation d\u2019un r\u00e9seau de personnes hautement qualifi\u00e9es<\/strong> en R&amp;D, en fabrication et en commercialisation des vaccins \u00e0 ARNm au Qu\u00e9bec.<\/span><span data-contrast=\"auto\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">Ce projet b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 1,5 M$. \u00c0 cette contribution s\u2019ajoutent 1 M$ provenant de partenaires industriels, pour un investissement total de 2,5 M$. <\/span><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2642 alignright\" src=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-300x300.png 300w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-150x150.png 150w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-768x768.png 768w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-780x780.png 780w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo-640x640.png 640w, https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/08\/Dr-Ciriaco-Piccirillo.png 1000w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<h4 style=\"text-align: right;\"><strong><span class=\"TextRun SCXW224304654 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW224304654 BCX0\">P<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">r <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW224304654 BCX0\">Ciriaco<\/span> <span class=\"NormalTextRun SpellingErrorV2Themed SCXW224304654 BCX0\">Piccirillo<\/span> <span class=\"NormalTextRun SCXW224304654 BCX0\">\u2013 <\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">D\u00e9partement de m<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">icrobiolog<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">ie et<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\"> Immunolog<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">ie,<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\"> Institut de recherche du Centre universitaire de sant\u00e9 McGill (IR-CUSM)<\/span><\/span><span class=\"LineBreakBlob BlobObject DragDrop SCXW224304654 BCX0\"><span class=\"SCXW224304654 BCX0\">\u00a0<\/span><br class=\"SCXW224304654 BCX0\" \/><\/span><span class=\"TextRun SCXW224304654 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW224304654 BCX0\">Cr\u00e9ation d<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">\u2019<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">un r\u00e9seau qu\u00e9b\u00e9cois d<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">\u2019<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">immunologie humaine pour soutenir l<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">\u2019<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">\u00e9cosyst\u00e8me provincial des vaccins <\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">&#8211; <\/span><\/span><span class=\"TextRun SCXW224304654 BCX0\" lang=\"FR-CA\" xml:lang=\"FR-CA\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW224304654 BCX0\">Financement de 1,5<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">\u202f<\/span><span class=\"NormalTextRun SCXW224304654 BCX0\">M$<\/span><\/span><span class=\"EOP SCXW224304654 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/strong><\/h4>\n<p style=\"text-align: right;\"><span data-contrast=\"none\">Les \u00e9tudes pr\u00e9cliniques, bien qu\u2019utiles, donnent une vision limit\u00e9e de l\u2019efficacit\u00e9 et de la s\u00e9curit\u00e9 des vaccins en d\u00e9veloppement. Pour pallier \u00e0 ces limites, les <strong>plateformes avanc\u00e9es d\u2019immunologie humaine<\/strong> offrent une alternative plus performante pour le d\u00e9veloppement et la caract\u00e9risation des vaccins-candidats, ce qui constitue un atout essentiel pour l\u2019industrie.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p style=\"text-align: left;\"><span data-contrast=\"none\">L\u2019\u00e9quipe du Pr Piccirillo d\u00e9veloppera une <\/span>plateforme avanc\u00e9e d\u2019immunologie humaine<span data-contrast=\"none\"> qui permettra d\u2019<strong>obtenir des informations cruciales pour le d\u00e9veloppement de vaccins<\/strong> telles que la compr\u00e9hension des m\u00e9canismes d\u2019action ainsi que l\u2019obtention de donn\u00e9es pour r\u00e9duire les risques et caract\u00e9riser les produits. La plateforme aidera donc les scientifiques et les compagnies qui d\u00e9veloppent de nouveaux vaccins \u00e0 mieux caract\u00e9riser leurs vaccins et la r\u00e9ponse immunologique qu&#8217;ils induisent. <\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">La plateforme consiste en une bo\u00eete \u00e0 outils qui comprend\u202f:\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Calibri\" data-listid=\"9\" data-list-defn-props=\"{&quot;335551671&quot;:0,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Calibri&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"0\" data-aria-level=\"1\"><span data-contrast=\"none\">Un mod\u00e8le organo\u00efde d\u2019amygdales humaines\u2009;<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Calibri\" data-listid=\"9\" data-list-defn-props=\"{&quot;335551671&quot;:0,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Calibri&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"0\" data-aria-level=\"1\"><span data-contrast=\"none\">Une technique de microscopie \u00e0 super-r\u00e9solution\u2009;<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Calibri\" data-listid=\"9\" data-list-defn-props=\"{&quot;335551671&quot;:0,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Calibri&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"0\" data-aria-level=\"1\"><span data-contrast=\"none\">Des \u00e9quipes multi-institutionnelles d\u00e9veloppant des tests pour \u00e9valuer les r\u00e9ponses des cellules B et T\u2009;<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Calibri\" data-listid=\"9\" data-list-defn-props=\"{&quot;335551671&quot;:0,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Calibri&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"0\" data-aria-level=\"1\"><span data-contrast=\"none\">Des outils d\u2019intelligence artificielle g\u00e9n\u00e9rant des profils complets de r\u00e9ponses induites par les vaccins.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">Cette activit\u00e9 de recherche inclura des collaborateurs industriels activement impliqu\u00e9s dans le d\u00e9veloppement de ces outils:\u00a0<\/span><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/cellcarta.com\/fr\/\">CellCarta<\/a><\/strong><span data-contrast=\"none\"> renforcera l\u2019effort de ph\u00e9notypage des lymphocytes T ;<\/span><\/li>\n<li><strong><a href=\"https:\/\/aramisbiotechnologies.com\/\">Aramis Biotechnologies<\/a><\/strong><span data-contrast=\"none\"> fournira les vaccins et les \u00e9chantillons de volontaires humains servant \u00e0 la preuve de concept.\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">Ce projet b\u00e9n\u00e9ficie du soutien du gouvernement du Qu\u00e9bec par l\u2019entremise de M\u00e9dicament Qu\u00e9bec, qui y investit 1,5 M$. \u00c0 cette contribution s\u2019ajoutent 1,2 M$ provenant de partenaires industriels, pour un investissement total de 2,7 M$. <\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans le cadre de son programme Innovations en technologies vaccinales, M\u00e9dicament Qu\u00e9bec investit 7,5\u202fmillions de dollars afin de soutenir six activit\u00e9s novatrices qui renforceront les&#8230;<\/p>\n<p class=\"readmore\"><a class=\"more-btn\" href=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/\">Lire la suite<\/a><\/p>\n","protected":false},"author":7,"featured_media":2839,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"og:description\" content=\"Dans le cadre de son programme Innovations en technologies vaccinales, M\u00e9dicament Qu\u00e9bec investit 7,5\u202fmillions de dollars afin de soutenir six activit\u00e9s novatrices qui renforceront les...Lire la suite\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/\" \/>\n<meta property=\"og:site_name\" content=\"M\u00e9dicament Qu\u00e9bec\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T12:39:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-14T13:28:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"St\u00e9phanie Bilodeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"St\u00e9phanie Bilodeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/\"},\"author\":{\"name\":\"St\u00e9phanie Bilodeau\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\"},\"headline\":\"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec\",\"datePublished\":\"2025-09-09T12:39:16+00:00\",\"dateModified\":\"2025-10-14T13:28:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/\"},\"wordCount\":2896,\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Annonce-vaccins_six_FR.png\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/\",\"name\":\"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Annonce-vaccins_six_FR.png\",\"datePublished\":\"2025-09-09T12:39:16+00:00\",\"dateModified\":\"2025-10-14T13:28:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#primaryimage\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Annonce-vaccins_six_FR.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Annonce-vaccins_six_FR.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/2025\\\/09\\\/09\\\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/medicamentquebec.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#website\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicamentquebec.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#organization\",\"name\":\"M\u00e9dicament Qu\u00e9bec\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"contentUrl\":\"https:\\\/\\\/medicamentquebec.ca\\\/wp-content\\\/uploads\\\/2021\\\/06\\\/logo-alt_mq.png\",\"width\":494,\"height\":266,\"caption\":\"M\u00e9dicament Qu\u00e9bec\"},\"image\":{\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicamentquebec.ca\\\/#\\\/schema\\\/person\\\/f380269566615a205fb9c18904b8b89f\",\"name\":\"St\u00e9phanie Bilodeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g\",\"caption\":\"St\u00e9phanie Bilodeau\"},\"url\":\"https:\\\/\\\/medicamentquebec.ca\\\/index.php\\\/author\\\/bilodeaus\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/","og_locale":"fr_FR","og_type":"article","og_title":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec","og_description":"Dans le cadre de son programme Innovations en technologies vaccinales, M\u00e9dicament Qu\u00e9bec investit 7,5\u202fmillions de dollars afin de soutenir six activit\u00e9s novatrices qui renforceront les...Lire la suite","og_url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/","og_site_name":"M\u00e9dicament Qu\u00e9bec","article_published_time":"2025-09-09T12:39:16+00:00","article_modified_time":"2025-10-14T13:28:47+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png","type":"image\/png"}],"author":"St\u00e9phanie Bilodeau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"St\u00e9phanie Bilodeau","Dur\u00e9e de lecture estim\u00e9e":"15 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#article","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/"},"author":{"name":"St\u00e9phanie Bilodeau","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f"},"headline":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec","datePublished":"2025-09-09T12:39:16+00:00","dateModified":"2025-10-14T13:28:47+00:00","mainEntityOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/"},"wordCount":2896,"publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/","url":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/","name":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec - M\u00e9dicament Qu\u00e9bec","isPartOf":{"@id":"https:\/\/medicamentquebec.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#primaryimage"},"image":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#primaryimage"},"thumbnailUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png","datePublished":"2025-09-09T12:39:16+00:00","dateModified":"2025-10-14T13:28:47+00:00","breadcrumb":{"@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#primaryimage","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2025\/09\/Annonce-vaccins_six_FR.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/medicamentquebec.ca\/index.php\/2025\/09\/09\/quatre-projets-pour-propulser-linnovation-en-vaccins-au-quebec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/medicamentquebec.ca\/"},{"@type":"ListItem","position":2,"name":"Six projets pour propulser l\u2019innovation en vaccins au Qu\u00e9bec"}]},{"@type":"WebSite","@id":"https:\/\/medicamentquebec.ca\/#website","url":"https:\/\/medicamentquebec.ca\/","name":"M\u00e9dicament Qu\u00e9bec","description":"","publisher":{"@id":"https:\/\/medicamentquebec.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicamentquebec.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/medicamentquebec.ca\/#organization","name":"M\u00e9dicament Qu\u00e9bec","url":"https:\/\/medicamentquebec.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/","url":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","contentUrl":"https:\/\/medicamentquebec.ca\/wp-content\/uploads\/2021\/06\/logo-alt_mq.png","width":494,"height":266,"caption":"M\u00e9dicament Qu\u00e9bec"},"image":{"@id":"https:\/\/medicamentquebec.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medicamentquebec.ca\/#\/schema\/person\/f380269566615a205fb9c18904b8b89f","name":"St\u00e9phanie Bilodeau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/430bead943158b41c0544d07cd629c34e3791d1d4fd5369260a2b69390142d9c?s=96&d=mm&r=g","caption":"St\u00e9phanie Bilodeau"},"url":"https:\/\/medicamentquebec.ca\/index.php\/author\/bilodeaus\/"}]}},"_links":{"self":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/comments?post=2637"}],"version-history":[{"count":39,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2637\/revisions"}],"predecessor-version":[{"id":2848,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/posts\/2637\/revisions\/2848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media\/2839"}],"wp:attachment":[{"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/media?parent=2637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/categories?post=2637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicamentquebec.ca\/index.php\/wp-json\/wp\/v2\/tags?post=2637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}